- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↑ 0.44%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option and its peers as on 2 July, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| Nippon India Pharma Fund-Growth Plan-Growth Option | 9.49% | 0.44% | 1.21% | 5.49% | 14.89% | 7.82% | 20.72% | 12.46% | 21.56% | 15.17% |
| SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH | 16.77% | -0.26% | 1.38% | 7.7% | 18.42% | 13.88% | 24.03% | 16.27% | 23.84% | 13.62% |
| SBI ESG Exclusionary Strategy Fund - Regular Plan - Growth | -3.34% | 0.75% | 0.51% | 3.97% | 11.01% | -1.04% | 10.27% | 10.12% | 11.85% | 11.83% |
| SBI INFRASTRUCTURE FUND - REGULAR PLAN - GROWTH | 3.6% | 0.18% | 0.03% | 1.57% | 15.81% | 0.91% | 18.02% | 18.56% | 17.92% | 14.99% |
| SBI PSU Fund - REGULAR PLAN -Growth | 2.04% | -0.14% | 0.09% | 0.56% | 4.38% | 7.09% | 27.69% | 23.2% | 18.14% | 14.29% |
| SBI CONSUMPTION OPPORTUNITIES FUND - REGULAR - GROWTH | -5.06% | 0.75% | 1.92% | 5.21% | 8.35% | -7.34% | 8.31% | 13.2% | 14.76% | 13.41% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -10.27% | 7.14% | 3.79% | 2.14% | 67.04% | 22.66% | -10% | 40.12% | 34.25% | -3.81% |
Discrete returns (monthly)
| Month | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -2.59% | 2.16% | 0.82% | -1.31% | -4.73% | 5.23% | -4.93% | 5.96% | 2.29% | 5.39% |
Returns from spefic dates
| Description | CAGR returns from 18 Oct 2021 (Nifty 50 2021 high) | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|---|
| Returns | 13.27% | 3.91% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 99.45% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 0.55% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 13.92% |
| Lupin Limited | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 8.45% |
| Divi's Laboratories Limited | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 6.41% |
| Dr. Reddy's Laboratories Limited | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 5.96% |
| Cipla Limited | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 5.42% |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP (INE437A01024) | Healthcare Services | 5.15% |
| MedPlus Health Services Limited | MEDPLUS (INE804L01022) | Retailing | 3.86% |
| Ajanta Pharma Limited | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 3.36% |
| Max Healthcare Institute Limited | MAXHEALTH (INE027H01010) | Healthcare Services | 3.24% |
| Vijaya Diagnostic Centre Limited | VIJAYA (INE043W01024) | Healthcare Services | 3.15% |
| Sai Life Sciences Limited | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 3.15% |
| Mankind Pharma Limited | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 2.87% |
| Aurobindo Pharma Limited | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 2.81% |
| IPCA Laboratories Limited | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 2.77% |
| GlaxoSmithKline Pharmaceuticals Limited | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 2.64% |
| Abbott India Limited | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 2.43% |
| Alkem Laboratories Limited | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 2.17% |
| JB Chemicals & Pharmaceuticals Limited | JBCHEPHARM (INE572A01036) | Pharmaceuticals & Biotechnology | 2.09% |
| Dr. Lal Path Labs Limited | LALPATHLAB (INE600L01024) | Healthcare Services | 2.02% |
| Thyrocare Technologies Limited | THYROCARE (INE594H01019) | Healthcare Services | 1.94% |
| Pfizer Limited | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 1.90% |
| Gland Pharma Limited | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 1.72% |
| Narayana Hrudayalaya Limited | NH (INE410P01011) | Healthcare Services | 1.67% |
| Emcure Pharmaceuticals Limited | EMCURE (INE168P01015) | Pharmaceuticals & Biotechnology | 1.51% |
| Sanofi Consumer Healthcare India Limited | SANOFICONR (INE0UOS01011) | Pharmaceuticals & Biotechnology | 1.16% |
| Suraksha Diagnostic Limited | SURAKSHA (INE877V01027) | Healthcare Services | 1.12% |
| Fortis Healthcare Limited | FORTIS (INE061F01013) | Healthcare Services | 1.11% |
| Sanofi India Limited | SANOFI (INE058A01010) | Pharmaceuticals & Biotechnology | 0.94% |
| Syngene International Limited | SYNGENE (INE398R01022) | Healthcare Services | 0.93% |
| Akums Drugs and Pharmaceuticals Limited | AKUMS (INE09XN01023) | Pharmaceuticals & Biotechnology | 0.89% |
| Anthem Biosciences Limited | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 0.88% |
| Biocon Limited | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 0.67% |
| AstraZeneca Pharma India Limited | ASTRAZEN (INE203A01020) | Pharmaceuticals & Biotechnology | 0.62% |
| Indoco Remedies Limited | INDOCO (INE873D01024) | Pharmaceuticals & Biotechnology | 0.38% |
| Concord Biotech Limited | CONCORDBIO (INE338H01029) | Pharmaceuticals & Biotechnology | 0.14% |
Portfolio data is as on date 31 March, 2026
NAV history
Nippon India Pharma Fund-Growth Plan-Growth Option - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 2 July, 2026 | 557.5002 | 0.44% |
| 1 July, 2026 | 555.0394 | -0.43% |
| 30 June, 2026 | 557.4174 | 0.73% |
| 29 June, 2026 | 553.3837 | 0.47% |
| 25 June, 2026 | 550.8208 | -0.19% |
| 24 June, 2026 | 551.8614 | 0.34% |
| 23 June, 2026 | 550.0091 | 0.51% |
| 22 June, 2026 | 547.2029 | 0.84% |
| 19 June, 2026 | 542.6632 | 0.59% |
| 18 June, 2026 | 539.4585 | 0.79% |
| 17 June, 2026 | 535.2471 | -0.12% |
| 16 June, 2026 | 535.9067 | -0.07% |
| 15 June, 2026 | 536.2874 | -0.42% |
| 12 June, 2026 | 538.5606 | 0.5% |
| 11 June, 2026 | 535.8811 | 0.21% |
| 10 June, 2026 | 534.7805 | -0.32% |
| 9 June, 2026 | 536.4763 | 0.56% |
| 8 June, 2026 | 533.4764 | -0.05% |
| 5 June, 2026 | 533.7434 | 0.53% |
| 4 June, 2026 | 530.9284 | 0.11% |
| 3 June, 2026 | 530.3524 | 0.35% |
| 2 June, 2026 | 528.5113 | -0.07% |
| 1 June, 2026 | 528.9056 | -0.81% |
| 29 May, 2026 | 533.2115 | -1.2% |
| 27 May, 2026 | 539.7005 | -0.04% |
| 26 May, 2026 | 539.9347 | -0.33% |
| 25 May, 2026 | 541.7249 | 0.15% |
| 22 May, 2026 | 540.9123 | -1.52% |
| 21 May, 2026 | 549.2545 | 0.41% |
| 20 May, 2026 | 546.9917 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Nippon India Pharma Fund-Growth Plan-Growth Option?
The latest NAV of Nippon India Pharma Fund-Growth Plan-Growth Option is 557.5002 as on 2 July, 2026.What are YTD (year to date) returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
The YTD (year to date) returns of Nippon India Pharma Fund-Growth Plan-Growth Option are 9.49% as on 2 July, 2026.What are 1 year returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
The 1 year returns of Nippon India Pharma Fund-Growth Plan-Growth Option are 7.82% as on 2 July, 2026.What are 3 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
The 3 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 20.72% as on 2 July, 2026.What are 5 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
The 5 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 12.46% as on 2 July, 2026.What are 10 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
The 10 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 12.46% as on 2 July, 2026.